TD Asset Management’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History

TD Asset Management’s Portfolio BSX.PRA Stock Details BSX.PRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-30,000	Closed	-$3.63M	–	1492
2023 Q1	$3.63M	Hold	30,000	–	–	﹤0.01%	826
2022 Q4	$3.44M	Hold	30,000	–	–	﹤0.01%	837
2022 Q3	$3.08M	Hold	30,000	–	–	﹤0.01%	870
2022 Q2	$3.04M	Hold	30,000	–	–	﹤0.01%	876
2022 Q1	$3.49M	Buy	+30,000	New	+$3.47M	﹤0.01%	916

Other funds holding BSX.PRA

LTI

Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

TD Asset Management's BSX.PRA Position: Q2 2023 in Review

TD Asset Management sold out of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) in Q2 2023, closing a stake of 30,000 shares — an estimated $3.63M sold.

TD Asset Management first reported a position in BSX.PRA in Q1 2022 and held it in 5 quarters. The position peaked at $3.63M in Q1 2023. 1 fund tracked by Wall St. Rank holds BSX.PRA as of Q2 2023.

TD Asset Management reported no remaining Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position as of Q2 2023 after selling out during the quarter.
TD Asset Management sold 30,000 Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A shares in Q2 2023, an estimated $3.63M.
TD Asset Management first reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in Q1 2022 and held it in 5 quarters.
TD Asset Management's Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position peaked at $3.63M in Q1 2023.
1 fund tracked by Wall St. Rank held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A as of Q2 2023.

Based on TD Asset Management's 13F filing for Q2 2023, filed 9 Aug 2023.